Overview
- Editors:
-
-
Richard C. Becker
-
Cardiovascular Thrombosis Research Center, USA
Coronary Care Unit, University of Massachusetts Medical School, Worcester
Access this book
Other ways to access
Table of contents (46 chapters)
-
-
Scientific Principles
-
-
The Biochemistry of Thrombosis
-
- Frederick A. Spencer, Richard C. Becker
Pages 5-13
-
- Pamela Sakkinen, Russell P. Tracy
Pages 15-28
-
Platelets
-
- Frederick A. Spencer, Richard C. Becker
Pages 31-49
-
Fibrinolysis
-
-
- Daniel T. Eitzman, William P. Fay, David Ginsburg
Pages 65-78
-
- Peter Carmeliet, Désiré Collen
Pages 79-99
-
- Bruce A. Keyt, Ted W. Love
Pages 101-120
-
Vascular Biology
-
-
- Harsch Sanchorawala, John F. Keaney Jr.
Pages 139-153
-
- Marco N. Diaz, Richard A. Cohen
Pages 155-168
-
Experimental Models of Plaque Rupture, Thrombosis, and Thrombolysis
-
-
- Narinder P. Bhalla, John A. Ambrose
Pages 183-205
-
- George S. Abela, Joel D. Eisenberg
Pages 207-217
-
-
Clinical Application of Scientific Principles
-
Front Matter
Pages 235-235
-
Thrombolytic Agents
-
- H. Joost Kruik, Willemien J. Kollöffel, Freek W. A. Verheugt
Pages 239-242
-
-
About this book
Teleologically, the hemostatic mechanism is among The of Coronary Thrombosis and the most fundamental yet complex physiologic pro- in essence, represents a heartfelt gift of cesses in humans. Early scientists and physicians were knowledge from a dedicated group of scientists and fascinated by the blood's ability to remain in a liquid clinicians, who collectively have set out on a mission state only to clot in response to vascular injury. The to minimize the societal impact of"hemostasis in the cellular and noncellular components of normal wrong place. " The book is divided into four distinct hemostasis took centuries to discover, and the intrica- sections: Part 1, Scientific Principles, lays down the cies of their delicate interactions are still being unrav- supporting foundation; Part 2, Clinical Application eled today. As is so often the case, an in-depth of Scientific Principles, places the knowledge base in appreciation of physiologic hemostasis, representing a a working perspective, directly applying science to basic life-sustaining sequence of events, paved the patient care; Part 3, New Dimensions, provides a way for understanding abnormal hemostasis or glimpse of tomorrow. Steering the field clear of se- pathologic thrombosis. Aristotle, Malpighi, and proclaimed victory and the dangers of complacency as Osier, representing but a few of the founding fathers we move into the 21st century, Part 4, Evolution of in the field, would undoubtedly be honored to see Thrombocardiology, focuses on laboratory standards, their observations form the template for lifesaving clinical trials, and drugs in development.
Editors and Affiliations
-
Cardiovascular Thrombosis Research Center, USA
Richard C. Becker
-
Coronary Care Unit, University of Massachusetts Medical School, Worcester
Richard C. Becker